Proteomic markers linking anxiety phenotypes to Alzheimers disease risk: a multi-analyte proteomic analysis
Costa, A. P.; Karim, H. T.; Farinas, M. F.; Geissinger, M. M.; Zeng, X.; Tudorascu, D. L.; Butters, M. A.; Karikari, T. K.; Andreescu, C.
Show abstract
Importance: Anxiety phenotypes - rumination, global anxiety, and worry (RAW) - are increasingly associated with Alzheimer's disease and related dementias (ADRD) risk, yet how anxiety phenotypes relate to coordinated, multi-system biology in the at-risk older adults is unknown. Objective: To map associations between anxiety phenotypes and plasma proteomic profile across five ADRD-relevant biological domains in older adults with high anxiety symptoms. Design, Setting, and Participants: Cross-sectional analysis of 110 older adults (aged 53-75 years) without dementia from the observational longitudinal RAW Brain study in Pittsburgh, Pennsylvania. Main Outcome(s) and Measure(s): Plasma was profiled with the NULISAseq CNS panel. Principal component (PC) analysis was conducted with Horn's parallel analyses across five ADRD-relevant biological domains (amyloid/tau pathology, inflammation, neurodegeneration, synuclein/synaptic disorders, and vascular) yielded 14 PCs (37.4-64.9% within-domain variance). Associations with each phenotype were tested by linear regression adjusted for age and sex, with Benjamini-Hochberg false discovery rate correction (p-FDR<0.05). Results: A neurodegeneration component (higher neuronal pentraxins and neurofilament light, with lower neurogranin) was associated with all three phenotypes (rumination, {beta} =0.26; global anxiety, {beta}= 0.39; worry, {beta} =0.36; all p-FDR<0.05). Inflammatory, VEGF receptor-ligand, and phospho-tau versus amyloid-processing components showed phenotype-specific associations, most often with worry severity. Conclusion and Relevance: Distinct anxiety phenotypes map onto dissociable plasma proteomic profiling, converging on a shared neurodegeneration axis reflecting neuronal injury, while diverging across neuroimmune, vascular, and proteostatic domains. These results point toward the biological heterogeneity of anxiety phenotypes as risk factors for ADRD. Further research is needed to clarify these biological pathways and explore targeted prevention strategies.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genetic risk for Alzheimer disease, cognition and Mild Behavioral Impairment in healthy older adults 95%
- Delayed primacy recall performance predicts post mortem Alzheimers disease pathology from unimpaired ante mortem cognitive baseline 94%
- Anterolateral entorhinal cortex thickness as a new biomarker for early detection of Alzheimer's disease 94%
Similar papers in this journal
- Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer’s disease 95%
- Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease 92%
- Age, sex and APOE -ε4 modify the balance between soluble and fibrillar β-amyloid in cognitively intact individuals: topographical patterns and replication across two independent cohorts 92%
Similar papers in this journal
- D-Methionine Improves Spatial Navigation and Attenuates Oxidative Stress and Amyloid Pathology in a Sex-Specific Manner 94%
- Sex Differences in Cognitive Performance in Alzheimer's Disease: Insights from the ADAS-Cog-13 94%
- Affective Neuropsychiatric Symptom Metrics in the National Alzheimers Coordinating Center Dataset 93%
Similar papers in this journal
- Analysis of whole genome sequence data shows association of Alzheimer's disease with rare coding variants in ABCA7, PSEN1, SORL1 and TREM2 91%
- Analysis of 470,000 exome-sequenced UK Biobank participants identifies genes containing rare variants which confer dementia risk 91%
- A Cell-Autonomous Role for the Vitamin B6 Metabolism Gene PNPO in Drosophila GABAergic Neurons 75%